Tenax Therapeutics, Inc.
NASDAQ: TENX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christopher T. Giordano
- Employees
- 4
- Headquarters
- Chapel Hill, United States
- IPO year
- 1994
- Market cap
- $228.6M
- Website
- https://www.tenaxthera.com
Loading TENX…
Loading profile data…Frequently asked questions about TENX
What does Tenax Therapeutics, Inc. (TENX) do?
Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinica...
Where does TENX trade?
Tenax Therapeutics, Inc. (TENX) trades on the NASDAQ Capital Market.
What sector is TENX in?
Tenax Therapeutics, Inc. (TENX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Tenax Therapeutics, Inc.?
Christopher T. Giordano is the chief executive officer of Tenax Therapeutics, Inc. (TENX).
Where is Tenax Therapeutics, Inc. headquartered?
Tenax Therapeutics, Inc. is headquartered in United States.
Does TENX pay a dividend?
Tenax Therapeutics, Inc. (TENX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TENX go public?
Tenax Therapeutics, Inc. (TENX) completed its initial public offering in 1994.